University Hospital, Lille: Scleroderma, Systemic trials
The registry lists 14 Scleroderma, Systemic studies with University Hospital, Lille as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 3 1No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Analysis of Dermal Fibroblasts and Immune Cells During Systemic SclerosisRecruitingNCT05273138
- Trichoscopy and Systemic SclerodermaRecruitingNCT04804930
- Deployment o the Multidisciplinary Prospective Cohort ImminentRecruitingNCT04334031Not applicable
- Implementation of a Biological Sample Collection in Systemic Sclerosis PatientsWithdrawnNCT04986514
- Prevalence of Hyperprolactinemia in Systemic SclerodermaCompletedNCT04746313
- Assessment of the Prevalence of Olfactory Disorders in Systemic SclerodermaTerminatedNCT04178616Not applicable
- Role of Eosinophil in Fibrogenesis of Systemic SclerosisCompletedNCT03816189
- Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.CompletedNCT03559465Not applicable
- Evaluation of Calcinosis in Systemic SclerosisCompletedNCT03340194
- Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.CompletedNCT03271333
- Evaluation of Aesthetic Impact in Patients With Systemic SclerosisCompletedNCT03271320
- Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis PatientsCompletedNCT02789670
- Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic SclerosisCompletedNCT01488214Not applicable
- Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDYCompletedNCT01295736Phase 3